Chamath Palihapitiya (Photographer: Scott Eells/Bloomberg via Getty Images)
Chamath Palihapitiya, the outspoken 'King of SPACs,' turns his eyes to biotech with plans to cash an $800M blank check
Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmark our IPO Tracker here.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
